IL50174A0 - Pharmaceutical compositions comprising an anti-inflammatory compound and a gastric lesions formation inhibitor - Google Patents

Pharmaceutical compositions comprising an anti-inflammatory compound and a gastric lesions formation inhibitor

Info

Publication number
IL50174A0
IL50174A0 IL50174A IL5017476A IL50174A0 IL 50174 A0 IL50174 A0 IL 50174A0 IL 50174 A IL50174 A IL 50174A IL 5017476 A IL5017476 A IL 5017476A IL 50174 A0 IL50174 A0 IL 50174A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
inflammatory compound
formation inhibitor
gastric lesions
lesions formation
Prior art date
Application number
IL50174A
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL50174A0 publication Critical patent/IL50174A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL50174A 1975-07-31 1976-07-30 Pharmaceutical compositions comprising an anti-inflammatory compound and a gastric lesions formation inhibitor IL50174A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3200575 1975-07-31
GB3200475 1975-07-31
GB2718476 1976-06-30

Publications (1)

Publication Number Publication Date
IL50174A0 true IL50174A0 (en) 1976-09-30

Family

ID=27258606

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50174A IL50174A0 (en) 1975-07-31 1976-07-30 Pharmaceutical compositions comprising an anti-inflammatory compound and a gastric lesions formation inhibitor

Country Status (10)

Country Link
JP (1) JPS5218831A (en)
AU (1) AU1643776A (en)
DE (1) DE2634409A1 (en)
DK (1) DK345676A (en)
FR (1) FR2319346A1 (en)
IL (1) IL50174A0 (en)
LU (1) LU75513A1 (en)
NL (1) NL7608503A (en)
NZ (1) NZ181635A (en)
SE (1) SE7608611L (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
IT1194677B (en) * 1980-08-05 1988-09-22 Italfarmaco Spa PHARMACEUTICAL COMPOSITION WITH ANTI-FLOGISTIC, ANTIPIRETIC AND ANALGIC ACTIVITY
DE3508665A1 (en) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt HETEROCYCLIC SULFIDES AND THEIR USE AS IMMUNO MODULATORS
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
US5164406A (en) * 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition

Also Published As

Publication number Publication date
FR2319346B1 (en) 1979-05-25
JPS5218831A (en) 1977-02-12
SE7608611L (en) 1977-02-01
NL7608503A (en) 1977-02-02
AU1643776A (en) 1978-02-02
LU75513A1 (en) 1977-04-15
NZ181635A (en) 1978-09-25
DK345676A (en) 1977-02-01
FR2319346A1 (en) 1977-02-25
DE2634409A1 (en) 1977-02-17

Similar Documents

Publication Publication Date Title
PH12363A (en) Oral pharmaceutical compositions of nandrolone-17 esters with a non-steroidal lipoid
NZ182190A (en) Clavulanic acid derivatives and pharmaceutical compositions
GB1550139A (en) Anti-inflammatory compositions for oral application
AU470771B2 (en) Anti-inflammatory and analgesic stilbene derivatives
AU502644B2 (en) Xanthine-containing pharmaceutical compositions
IL50174A0 (en) Pharmaceutical compositions comprising an anti-inflammatory compound and a gastric lesions formation inhibitor
AU1554076A (en) Pharmaceutical Compositions and Compounds
AU502645B2 (en) Organ 0 titanate chelates
AU504840B2 (en) Medicinal compositions
NZ185035A (en) Benz-acylbenzimidazol-2-yl-(carboxylic acid or methanol) derivatives and pharmaceutical compositions
GB1532094A (en) Preparation of benzenecarboxylic acids
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions
AU506442B2 (en) Prostaglandin analogues and pharmaceutical compositions
AU498557B2 (en) D-homosteroids & pharmaceutical compositions
AU2060576A (en) Antiinflammatory pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
ZA761012B (en) Pharmaceutical compositions
AU499217B2 (en) Pharmaceutical compositions
IL49867A (en) Pharmaceutical compositions for preventing gastro-intestinal ulcers comprising quinazolinone derivatives and a non-steroidal anti-inflammatory agent
IL49698A0 (en) Pharmaceutical compositions comprising a certain 1-phenoxy-2-aminopropane derivative
JPS51118794A (en) Pharmaceutical compound * production thereof and composition
NZ181736A (en) 1-azidoalkylimid azoles and pharmaceutical compositions
IL49355A0 (en) Pharmaceutical compositions comprising sodium-l-ascorbate-2-sulfate
AU1172076A (en) Pharmaceutical compositions
NZ179859A (en) 2-phenyl-pyrol(id)in-4-yl -pyridine derivatives and pharmaceutical compositions